Summary by Futu AI
Yao Shi Bang Co., Ltd. (the "Company") announced its unaudited interim business performance for the six months ended June 30, 2024. During the period, the Company's revenue reached RMB 8,813.9 million, an increase of 10.6% compared to the same period last year. Gross profit increased to RMB 881.7 million, a growth of 7.9%, and the profit for the period turned from a loss of RMB 317.66 million in the same period last year to a profit of RMB 13.4 million. The adjusted net profit under non-international financial reporting standards was RMB 91.4 million, an increase of 30.3% year-on-year. The total GMV reached RMB 23,830 million, an increase of 8.1% year-on-year. The Company maintained high-quality growth in its operations during the reporting period, actively responded to relevant national policies, empowered external market entities with technology, and promoted the high-efficiency and high-quality development of the external pharmaceutical market. During the reporting period, the Company did not distribute any dividends.
